Alan Huang's most recent trade in Tango Therapeutics Inc was a trade of 190,181 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 1, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tango Therapeutics Inc | Alan Huang | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 190,181 | 190,181 | - | - | Stock Option (Right to Buy) | |
| Tango Therapeutics Inc | Alan Huang | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 31,697 | 167,584 | - | 0 | Common Stock | |
| Tango Therapeutics Inc | Alan Huang | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Tango Therapeutics Inc | Alan Huang | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2021 | 169,859 | 169,859 | - | - | Stock Option (Right to Buy) |